Tranexamic acid and trauma

James Jarman and Andrew Brier
Med J Aust 2014; 200 (5): . || doi: 10.5694/mja13.00021
Published online: 17 March 2014

To the Editor: Gruen and colleagues1 have not accurately represented the current safety data on the risk of vascular occlusive events (VOE) with tranexamic acid (TxA), including deep vein thrombosis (DVT) and pulmonary embolism (PE).

  • Department of Anaesthetics, Mackay Base Hospital, Mackay, QLD.

Competing interests:

No relevant disclosures.

  • 1. Gruen RL, Jacobs IG, Reade MC; PATCH-Trauma study investigators. Trauma and tranexamic acid. Med J Aust 2013; 199: 310-311. <MJA full text>
  • 2. Ker K, Edwards P, Perel P, et al. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012; 344: e3054.
  • 3. Shakur H, Roberts I, Bautista R, et al; CRASH-2 Trial Collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo controlled trial. Lancet 2010; 376: 23-32.
  • 4. Morrison J, Dubose J, Rasmussen T, Midwinter M. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg 2012; 147: 113-119.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.